From: Increased risk for uterine cancer among first-degree relatives to Swedish gastric cancer patients
Observed number | Proportion [%] | LL 95% | UL 95% | Proportion [%] in Sweden 1970 | Proportion [%] in Sweden 2010 | Reference outside CI | |
---|---|---|---|---|---|---|---|
Uterus | 9 | 15.52 | 6.9 | 25.86 | 6.01 | 5.37 | CI above reference |
Stomach | 8 | 13.79 | 5.17 | 22.41 | 5.4 | 1.16 | No |
Colon/rectum | 8 | 13.79 | 5.17 | 22.41 | 11.84 | 10.7 | No |
Breast | 8 | 13.79 | 5.17 | 22.41 | 23.72 | 32.38 | CI below reference |
Unspecified location | 5 | 8.62 | 1.72 | 17.24 | 3.48 | 2.58 | No |
Ovary and Fallopian tube | 4 | 6.9 | 1.72 | 13.79 | 7.06 | 3.03 | No |
Liver and biliary system | 3 | 5.17 | 0 | 12.07 | 3.46 | 1.53 | No |
Lung and airways | 3 | 5.17 | 0 | 12.07 | 2.82 | 6.71 | No |
Cervix | 3 | 5.17 | 0 | 12.07 | 5.72 | 2.03 | No |
Thyroid | 2 | 3.45 | 0 | 8.62 | 1.49 | 1.59 | No |
Head and neck | 1 | 1.72 | 0 | 5.17 | 1.59 | 1.8 | No |
Kidney and urinary tract excl prostate | 1 | 1.72 | 0 | 5.17 | 5.3 | 3.75 | No |
Malignant melanoma | 1 | 1.72 | 0 | 5.17 | 2.42 | 5.72 | No |
Bone and soft tissue | 1 | 1.72 | 0 | 5.17 | 1.08 | 0.61 | No |
Blood and lymphatic tissue | 1 | 1.72 | 0 | 5.17 | 7.08 | 6.91 | CI below reference |